Background and Aim: Removal of neoplastic polyps is important for colorectal cancer prevention. The primary aim was to compare the complete resection rate of diminutive (≤ 5 mm) or small colorectal polyps (6-10 mm) using cold snare polypectomy (CSP) versus hot snare polypectomy (HSP). Methods: To April 2018, databases of Medline, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science were searched for randomized controlled trials comparing CSP and HSP for diminutive or small colorectal polypectomy. Two authors independently assessed trial quality and extracted data. We contacted study authors for additional information. We used the Mantel-Haenszel method for binary endpoints and inverse variance method for continuous outcomes. Subgroup analysis was conducted to explore sources of heterogeneity. Results: Twelve trials involving 2481 patients and 4535 polyps were analyzed. Regarding complete resection rate, there was no statistical significance between CSP and HSP (odds ratio [OR] 0.86, 95% confidence interval [CI] 0.60-1.24). CSP shows more immediate bleeding cases than HSP in per-lesion analysis while no statistical significance in bleeding needing treatment (OR 1.99, 95% CI 0.59-6.75). In terms of all adverse events, both perlesion and per-patient analysis revealed no difference (OR 1.49, 95% CI 0.87-2.56 and 0.57, 0.11-2.97, respectively). As far as post-polypectomy bleeding is concerned, there was also no statistical significance between CSP and HSP. Regarding procedure time, CSP was superior to HSP (standard mean difference À1.04, 95% CI À1.22 to À0.87). Conclusions: Cold snare polypectomy is a safe, efficient, and effective polypectomy technique for diminutive or small colorectal polyps.
Introduction
Colorectal cancer is the third most commonly diagnosed malignancy and the second leading cause of cancer death globally, accounting for about 1.7 million new cases and almost 832 000 deaths in 2015. 1 The endoscopic resection of colorectal adenomas is clinically important to reduce colorectal cancer mortality by interrupting the adenoma-to-carcinoma sequence. 2 For colorectal polyps sized ≤ 10 mm, there are two main endoscopic resection techniques, including hot snare polypectomy (HSP) and cold snare polypectomy (CSP). Performed with electrocautery, HSP is conventionally used for polypectomy by the ablation of marginal tissue to promote complete resection and hemostasis. However, there is little proof supporting these assertions. In contrast, the procedure of HSP itself may lead to adverse events such as post-polypectomy bleeding and perforation due to the thermal damage of the intestinal wall. 3, 4 Horiuchi et al. reported that the rate of arterial injury in the submucosal layer after HSP is as high as 39%, which is a main cause of post-polypectomy bleeding. 5 Another study found that 60% of hot resections advanced to the deep submucosa and 20% to the muscularis propria, where the vessel diameter was larger and the number of large vessels was greater. 6 More recently, polyp resection without electrocautery, called CSP, has attracted the attention of colonoscopists because of shorter procedure time and low incidence of adverse events, especially post-polypectomy bleeding. A multicenter randomized controlled trial from Japan observed more post-polypectomy bleeding cases in the HSP group compared with CSP group. 7 Additionally, European Society of Gastrointestinal Endoscopy (ESGE) clinical guidelines recommend the use of CSP as the preferred technique to remove diminutive polyps ≤ 5 mm and sessile polyps 6-9 mm in size. 8 However, Zhang et al. reported that CSP did not decrease the incidence of adverse events or have shorter procedure time Accordingly, the advantages of CSP over HSP remain unclear.
Actually, a definitive conclusion as to whether CSP is superior to HSP should emphasize on the effectiveness, safety, and efficiency. Until now, there was seldom comparison between CSP and HSP, and the long-term follow-up studies still lacking on the recurrence after polypectomy. Nevertheless, a short-term analysis of effectiveness and safety of these two techniques could be performed on existing data.
Therefore, the aim of this systematic review and meta-analysis was to compare the effectiveness between CSP and HSP in treatment of colorectal polyps sized ≤ 10 mm and evaluate the safety and efficiency of these two techniques.
Methods
Eligibility criteria. The methods for the analysis and generation of inclusion criteria were based on the Cochrane Collaboration guidelines and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. According to population, interventions, comparators, outcome measures, and setting criteria, we included patients from randomized controlled trials that compared CSP and HSP for either or both the effectiveness or safety in the treatment of colorectal polyps sized ≤ 10 mm, regardless of whether or not the data were part of the primary or secondary endpoint. We excluded all prospective studies that had only one arm or did not include CSP in one of the arms.
Outcomes measures. Primary outcome was to compare the complete resection rate between CSP and HSP, defined as a negative pathological margins (R0 resection) from the edge of the resected polyps 3 or a negative biopsy from the polypectomy site. 7, [9] [10] [11] Secondary endpoints was to compare the procedure time and safety which including number of all adverse events, immediate bleeding, post-polypectomy bleeding between the two groups. Procedure time involves total colonoscopy time and specific polypectomy time. Specific polypectomy time is defined as the time of finishing polypectomy per-lesion. Post-polypectomy bleeding is defined as hemorrhage after colonoscopy requiring endoscopic hemostasis, oral antithrombotic administration, emergency department presentation, or hospitalization within 30 days of the procedure. 5, 7, 10, 12 Search strategy. To April 2018, we searched the following electronic databases starting with their dates of inception: Medline, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science using the key words "cold snare" and "polypectomy." The search detail is reported in the Supporting Information. In addition, citations in eligible studies, reviews, or meta-analyses related to CSP in colorectal polyps were also screened. The language was limited to studies published in English. Figure 1 shows the study flow diagram.
We obtained the text of citations considered as potentially eligible by at least 1 of the 2 reviewers. Next, the two reviewers independently screened the full texts of articles and meeting abstracts for eligibility using all inclusion criteria. Disagreements were resolved by discussion. The abstracts were not blinded for authors, institutions, or journals during review. When duplicate studies from the same institution or study group were found, the most recent or most informative report was included. Even if the study group was included in multiple articles, the data were applied when the study population was different in each study.
Quality assessment. The Cochrane Handbook for Systematic Reviews of Interventions (Figs S1 and S2) was used to assess the quality of the included studies. This process was performed independently by two investigators (Q. J. Y. and J. H. X.), and disagreement was resolved by discussion.
Data collection. Two authors (Q. J. Y. and J. H. X.) independently extracted information. When initial conclusions did not agree between the two reviewers, differences were resolved by discussion. In addition, we also contacted five authors 7, [12] [13] [14] [15] for missing information, three 7, 12, 13 of whom replied to us with detailed information. The abstracted data included information about (i) characteristics of the included studies: author, publication year, country, random method; (ii) characteristics of the population in each included study: number of included patients, mean age, gender distribution, number of lesions, mean lesion size, histopathology of the lesion, morphology of the lesion, and histologic and macroscopic diagnostic criteria; (iii) intervention: type of device used, whether submucosal injection available; (iv) outcomes: complete resection rate, the procedure time, number of all adverse events, immediate bleeding, and post-polypectomy bleeding. The macroscopic and histologic findings were assessed based on Paris classification 16 and Vienna classification, 17 respectively.
Data analysis. Data were extracted, pooled, and analyzed using the RevMan 5.3 software (Cochrane Collaboration, Oxford, UK). All of analyses were performed according to original treatment allocation (intention-to-treat analysis). For binary outcome data, the odds risks (OR) and 95% confidence intervals (CIs) were estimated using the Mantel-Haenszel method. For continuous outcome data, standard mean differences and 95% CIs were estimated using the inverse variance weighting. For those studies in which means and/or standard deviations (SDs) were not reported, the respective authors were contacted for additional information. The between-study heterogeneity was tested and quantified using the Cochran Q statistic and the I 2 statistic, respectively. An I 2 value more than 50% was considered significant heterogeneity. Potential sources of heterogeneity were explored by different sensitivity analyses: comparing fixed-effect versus random-effect models (thus incorporating heterogeneity by using the second method), performing subgroups analyses and influence analyses (calculating pooled estimates omitting one study at a time). We used funnel plot to evaluate publication bias with a P value < 0.10 defined as significant asymmetry.
Results
Selected studies. A total of 362 studies were identified by our literature search. After scanning titles and abstracts, we discarded 226 duplicate studies retrieved through multiple electronic databases. Another 122 irrelevant articles were excluded based on the titles and abstracts. After the eight full texts of remaining articles and six remaining abstracts were reviewed, two meeting abstracts 14, 18 were excluded for insufficient data. Finally, 12 randomized controlled trials (RCTs) were included in our meta-analysis, including eight full texts of articles 3, 5, 7, [9] [10] [11] 15, 19 and four meeting abstracts. 12, 13, 20, 21 Study characteristics. Total of 2481 patients and 4535 polyps were included in the meta-analysis. Among the 12 included studies, one was designed as a three-arm trial, which compared the efficacy among cold biopsy forceps polypectomy, CSP, and HSP. 11 Only the CSP group and HSP group were conducted in our analysis. All other studies were two-arm study designs comparing CSP versus HSP. All included studies were published from 2010 to 2018. Countries in which the studies were conducted were Japan (n = 8), Greece (n = 2), China (n = 1), and the United States (n = 1). The mean or median age of patients treated with CSP ranged from 59.4 to 67.0 years old, while those of patients treated with HSP ranged from 58.3 to 67.3 years old, which were described in seven studies. The ratio of men to women in all described cases was 1.06 to 3.17 among CSP cases and 1.36 to 3.00 among HSP cases. All studies investigated lesions measuring less than 10 mm in diameter. Significant difference was noted in the average size between the cold and HSP groups in one study. 15 Ten studies described the polyp retrieval rate, with HSP groups ranging from 93% to 100% and CSP group ranging from 92.8% to 100%. Six studies provided data about complete resection rate, and one author of three studies replied to us with detailed information. The data of the SD of procedure time of one study were obtained by personal communication with the author.
7 Table 1 shows the characteristics of the included studies.
Risk of bias of included studies. Quality assessments for individual studies are presented in Figures S1 and S2. Five studies (41.7%) did not report on random sequence generation, and five studies (41.7%) did not clarify how allocation concealment was performed. All studies showed a high risk of performance bias for blinding of the colonoscopists was impossible. Eight studies (66.7%) had unclear risk of detection bias for no mention of blinding of outcome assessors. One study had high risk of detection bias, because the colonoscopists was also hardly blind to evaluate the resection width. Three studies published as abstract have unclear risk of other bias. One of the two studies had high risk of other bias for baseline imbalance in polyp size between two groups. 15 The other one had high risk of other bias for baseline imbalance in En bloc resection. 22 Complete resection rate. Six studies reported complete resection rate. We contacted two authors of four papers for complete resection rate and one of them replied to us with detailed information of three papers. 5, 13, 19 Finally, nine studies were included for analysis. These reports included a total of 1021 lesions removed by CSP and 1012 removed by HSP. The complete resection rate for these studies ranged from 77.3% to 98.2% in the CSP group and from 85.0% to 98.5% in the HSP group. There was no statistical significance between CSP and HSP in complete resection rate (OR 0.86, 95% CI 0.60-1.24, P = 0.41), with heterogeneity (I 2 , 45%) (Fig. 2) .
Procedure time. Eight studies reported procedure time. 5, 7, 9, 12, 13, 15, 19, 20 Three studies 7, 9, 12 reported specific polypectomy time. Base on the significant heterogeneity (P < 0.00001, I 2 = 100%) (Fig. S3) , the results were not included in the analysis. Another two studies 13, 20 not included in the metaanalysis is due to lacking of SD and incomplete information as abstract, respectively. The other three studies reported total colonoscopy time. Thus, the three studies with 283 patients removed in CSP group and 281 patients in HSP group were included in the analysis. It showed that CSP was significantly shorter in total colonoscopy time than HSP (standard mean difference À1.04, 95% CI À1.22 to À0.87, P < 0.00001), with no heterogeneity (I 2 , 0%) (Fig. 3 ). An evaluation of publication bias was difficult to carry out due to the small number of studies.
Adverse events. Adverse events, including bleeding, perforation, hematochezia, diarrhea, constipation, abdominal pain, and abdominal discomfort, were described in all 12 studies and observed in 10 studies. No perforation occurred in any of the 12 studies. Because the between-study heterogeneity of these 12 studies was high (P = 0.0003, I 2 = 71%), we conducted subgroup analyses according to the analytical method (per-lesion vs per-patient). We found that the results in per-lesion analysis showed less heterogeneity (P = 0.71, I 2 = 0%), and the results in per-patient analysis was still high heterogeneity (P < 0.0001, I 2 = 81%). Both perlesion and per-patient analysis showed no difference between CSP and HSP in adverse events (OR 1.49, 95% CI 0.87-2.56, P = 0.14 and 0.57, 0.11-2.97, 0.51, respectively) (Fig. 4 ). An evaluation of publication bias was also difficult to carry out due to the small number of studies.
Immediate bleeding. Immediate bleeding was described in 10 studies and observed in six studies, 5, 7, 9, 10, 15, 21 with different definitions. One study in which endoscopists performed polypectomy without discontinuation of warfarin was removed, 5 because anticoagulant therapy increases the risk of bleeding. We conducted subgroup analyses according to the analytical method (per-lesion vs per-patient). There was statistical significance between CSP and HSP in per-lesion analysis (OR 2.03, 95% CI 1.09-3.77, P = 0.03) (Fig. S4) . There is no heterogeneity in perlesion analysis (I 2 = 0%) and high heterogeneity in per-patient Meta-analysis of cold and hot snare polypectomy J Qu et al.
analysis (I 2 = 68%). We also conducted subgroup analyses according to the definitions of immediate bleeding (just bleeding vs need treatment). The result shows that there is no significant difference between CSP and HSP in immediate bleeding needing treatment subgroup (OR 1.99, 95% CI 0.59-6.75, P = 0.27), although overall effect shows that CSP maybe increase the risk of immediate bleeding (OR 2.86, 95% CI 1.34-6.10, P = 0.006) (Fig. 5 ). An evaluation of publication bias was also difficult to carry out due to the small number of studies.
Post-polypectomy bleeding. Post-polypectomy bleeding was described in all 12 studies and observed in only five studies. 5, 7, 12, 20, 21 The study in which endoscopists performed polypectomy without discontinuation of warfarin was also removed for anticoagulant therapy increasing the risk of bleeding. 5 We also conducted subgroup analyses, and there was also no statistical significance between CSP and HSP in both per-lesion and perpatient analysis (OR 0.74, 95% CI 0.21-2.64, P = 0.65 and 0.65, 0.11-4.04, 0.65, respectively), with both little or no heterogeneity (I 2 = 0%) (Fig. 6 ). An evaluation of publication bias was also difficult to carry out due to the small number of studies.
Discussion
In this study, we systematically reviewed the literature for techniques used to remove colorectal polyps. In our meta-analysis, the complete resection rate, number of all adverse events, immediate bleeding needing treatment, and post-polypectomy bleeding in the CSP group were not significantly different from those in the HSP group. Furthermore, it showed that CSP has a significantly shorter procedure time compared with HSP. To the best of our knowledge, there are seldom studies to compare the effectiveness and safety of CSP and HSP for the treatment of colorectal polyps sized less than or equal to 10 mm. Recently, Shinozaki et al. 23 conducted a meta-analysis comparing CSP with HSP for resecting small colorectal polyps. Compared with their study, we not only more accurately described the size of polyps but also carried out a more systematic and detailed literature search to include four more meeting abstracts. We also innovatively introduced the assessment of immediate bleeding between CSP and HSP to our analysis and got a clinically valuable result.
In the safety of polypectomy, CSP does not decrease the incidence post-polypectomy bleeding and other adverse effects, which is not consistent with previous studies. [3] [4] [5] 24 The following points may contribute to these results. Firstly, in clinical practice, the occurrence of post-polypectomy bleeding is rare, which is observed approximately 1.6% of patients. 25 Larger sample size studies are required to determine whether CSP causes significantly less delayed bleeding and other adverse reactions than HSP. Secondly, the colorectal polyps we included were too small to produce serious adverse reactions, such as perforation.
Although various subgroup analysis and sensitivity analysis result heterogeneity on immediate bleeding and adverse events especially on per-patient analysis still exist, which may be related to the following factors. First, the definitions of outcomes such as immediate bleeding, post-polypectomy time, and adverse events are various in different studies. In detail, six studies defined it as immediate bleeding requiring therapeutic intervention, 3, 5, [9] [10] [11] 19 while the other two studies defined it as continuous hemorrhage for more than a period of time. 7, 15 Similarly, the various definitions of complete resection can also influence the judgment of immediate bleeding because biopsy itself can also cause bleeding. Second, submucosal injection in some studies was available while others' was not. What is more, submucosal injection was even used variably between the two groups in the same study. Third, the studies had a large variability in the polyp size with a relatively wide range, which is closely related to the occurrence of bleeding and other adverse events. Consistent methods for population inclusion, specimen detection, and evaluation are urgently needed in future.
In the effectiveness of polypectomy, the result is consistent with previous analysis, 23 indicated that CSP could be one of the standard techniques used of the resection of diminutive or small colorectal polyps. It is worth noting that the following factors maybe affect the complete resection rate. First, the CARE study showed that the skill and experience of each physician is another important factor affecting the rate of complete resection. 26 In our analysis, most of the included studies clearly point out that polypectomy of both group is performed by experienced endoscopists. 5, 7, [9] [10] [11] 15, 19 Second, the more important characteristics to determine malignant potential of a polyp are size and histological findings. In our analysis, all studies investigated lesions smaller than 10 mm in diameter. Recently, cold snare resection has been applied for larger polyps. [27] [28] [29] In Australia, 34 patients with 41 large sessile serrated polyps (SSPs) (10-35 mm) undertook piecemeal resection using CSP, which showed no significant adverse events and no evidence of recurrence at a median of 6 months. 27 Last but not the least, all of the studies we included used traditional snares. Dedicated cold snare was specifically designed for CSP, which is thinner, stiffer, and has a different shape compared with the traditional snare. Horiuchi et al. have reported that complete resection rate was significantly greater with dedicated cold snares than traditional cold snares (P = 0.015). 30 Future research can further compare the effectiveness and safety between the dedicated CSP and HSP.
Shorter procedure time is one of the superiorities of CSP, which may improve the efficiency of endoscopists and reduce the adverse events of patients. Because the definition of procedure time in the literature is vague and heterogeneous, we artificially divided it into total colonoscopy time and specific polypectomy time. The shorter total colonoscopy time likely relates to the lack of the time to prepare the electrocautery equipment. Submucosal injection could produce a cushion for safety in HSP. Paspatis et al. held that the extra time elevating the mucosal layer increased the time in the HSP group, 15 while both Ichise et al. and Horiuchi et al. reported that the total colonoscopy time of CSP was significantly shorter than that of HSP, even without submucosal injection. 5, 19 Specific polypectomy time was also shorter in CSP groups (OR À1.24, 95% CI À3.22-0.74, P = 0.22) (Fig. S3) , although not significantly. The strong heterogeneity of specific polypectomy time might due to the heterogeneity of the experience of different endoscopists and small number of studies. Further study would be needed to evaluate whether CSP consumes really less specific polypectomy time than HSP.
Our study has a number of limitations. To start with, the rate of recurrence after CSP and HSP was not investigated, which is virtually important for colorectal cancer prevention. By the date this manuscript was sent out, only one study with 249 patients, published as abstract, has performed a prospective controlled study to evaluate the local residual recurrence after cold polypectomy and hot polypectomy. 22 The result showed none in either group showed residual recurrence in 1 year follow-up. Thus, the longterm follow-up studies on a large scale of CSP and HSP are warranted for future studies. Secondly, four studies published only as abstracts provided incomplete data, which may reduce the strengths of our results.
Despite these limitations, our meta-analysis included a large sample size with 2481 patients and used the subgroup analyses to overcome the heterogeneity among the different studies. We also used the comprehensive approach of the Cochrane Collaboration for conducting systematic reviews, including a very sensitive search strategy, a duplicate and independent selection and data abstraction processes, and a rigorous evaluation of study quality. Interestingly, we find that the risk of immediate bleeding requiring treatment did not increase by CSP, as compared with HSP.
In conclusion, CSP is a time-saving polypectomy technique for colorectal polyps less than 10 mm in diameter with comparable effectiveness and safety to HSP. Further research should continue to explore the upper limit polyp diameter by using CSP and its longterm recurrence.
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